Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Demaria

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2011
TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivoFanny Bouquet, Anupama Pal, Karsten A Pilones, et al.
Journal for Immunotherapy of Cancer|April 8, 2021
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?Sandra Demaria, Chandan Guha, Jonathan Schoenfeld, et al.
Cancer Immunology Research|December 14, 2019
Aggressive Mammary Cancers Lacking Lymphocytic Infiltration Arise in Irradiated Mice and Can Be Prevented by Dietary InterventionCoral Omene, Lin Ma, Jade Moore, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancerSylvia Adams, Sandra Demaria, Darawan Rinchai, et al.
Journal for Immunotherapy of Cancer|June 23, 2016
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common ruleHoward L Kaufman, Lisa H Butterfield, Pierre G Coulie, et al.
Iscience|July 2, 2025
Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structuresRichard H Mebane, Teia Noel, Nathan Ing, et al.
Oncoimmunology|October 21, 2016
Trial Watch: Immunotherapy plus radiation therapy for oncological indicationsErika Vacchelli, Norma Bloy, Fernando Aranda, et al.
Cancer Immunology Research|May 20, 2016
Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune ResponsivenessLance D Miller, Jeff A Chou, Michael A Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2012
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancerSylvia Adams, Lina Kozhaya, Frank Martiniuk, et al.
Journal of Translational Medicine|May 10, 2022
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021Paolo A Ascierto, Allison Betof Warner, Christian Blank, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2011
TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivoFanny Bouquet, Anupama Pal, Karsten A Pilones, et al.
Journal for Immunotherapy of Cancer|April 8, 2021
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?Sandra Demaria, Chandan Guha, Jonathan Schoenfeld, et al.
Cancer Immunology Research|December 14, 2019
Aggressive Mammary Cancers Lacking Lymphocytic Infiltration Arise in Irradiated Mice and Can Be Prevented by Dietary InterventionCoral Omene, Lin Ma, Jade Moore, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancerSylvia Adams, Sandra Demaria, Darawan Rinchai, et al.
Journal for Immunotherapy of Cancer|June 23, 2016
Society for immunotherapy of cancer (SITC) statement on the proposed changes to the common ruleHoward L Kaufman, Lisa H Butterfield, Pierre G Coulie, et al.
Iscience|July 2, 2025
Spatial transcriptomic analysis of immune checkpoint blockade response in triple negative breast cancers with tertiary lymphoid structuresRichard H Mebane, Teia Noel, Nathan Ing, et al.
Oncoimmunology|October 21, 2016
Trial Watch: Immunotherapy plus radiation therapy for oncological indicationsErika Vacchelli, Norma Bloy, Fernando Aranda, et al.
Cancer Immunology Research|May 20, 2016
Immunogenic Subtypes of Breast Cancer Delineated by Gene Classifiers of Immune ResponsivenessLance D Miller, Jeff A Chou, Michael A Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2012
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancerSylvia Adams, Lina Kozhaya, Frank Martiniuk, et al.
Journal of Translational Medicine|May 10, 2022
The "Great Debate" at Melanoma Bridge 2021, December 2nd-4th, 2021Paolo A Ascierto, Allison Betof Warner, Christian Blank, et al.
Pageof 16